Summary & Overview
HCPCS G8547: Intent to Report Ischemic Vascular Disease Measures
HCPCS Level II code G8547 denotes the intent to report the ischemic vascular disease (IVD) measures group, a quality-reporting marker used by providers and health systems that submit performance data on IVD-related care. Nationally, quality reporting codes like G8547 support measurement of preventive care, secondary prevention, and outcomes for patients with ischemic vascular conditions and factor into payer quality programs and public reporting.
This analysis covers major national payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the code’s clinical and administrative purpose, typical service context, and what to expect in payer adoption and reporting processes. The publication also summarizes benchmark considerations, relevant policy updates affecting quality measure submission, and the clinical context for ischemic vascular disease measure groups.
The content is designed to help billing managers, quality officers, and health policy professionals understand the role of HCPCS Level II code G8547 in national quality reporting frameworks, where it is applied, and which payers commonly interact with such reporting codes.
Billing Code Overview
HCPCS Level II code G8547 indicates intent to report the ischemic vascular disease (IVD) measures group. This code is used to signal that a provider or reporting entity plans to submit quality or performance data related to ischemic vascular disease.
-
Service type: Quality reporting/measure group reporting
-
Typical site of service: Administrative or clinical reporting contexts associated with outpatient or ambulatory cardiovascular care settings
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a history of hypertension, hyperlipidemia, and prior transient ischemic attack presents for performance measurement and quality reporting related to ischemic vascular disease (IVD). The clinical workflow begins with the outpatient visit in a primary care or cardiology clinic where the clinician documents a diagnosis of ischemic vascular disease and reviews current medications, most notably antiplatelet therapy (aspirin or P2Y12 inhibitor), statin therapy, blood pressure control, and smoking status. The care team verifies medication reconciliation, assesses adherence, and orders or documents recent laboratory results (lipid panel, liver function tests) and blood pressure readings. Counseling on lifestyle modification (tobacco cessation, diet, exercise) is provided, and referrals are placed as needed to cardiology, vascular medicine, or smoking cessation programs.
Typical sites of service include an outpatient clinic, ambulatory care center, or physician office where quality reporting for chronic ischemic vascular disease is captured. The patient encounter typically results in documentation that supports reporting of the ischemic vascular disease measures group (G8547) to payors and registries, including record of antiplatelet therapy, statin therapy, blood pressure control, and smoking status.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure |